• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉扩张患者整体纤溶活性的评估:整体纤溶能力。

Evaluation of overall fibrinolytic activity in patients with coronary artery ectasia: global fibrinolytic capacity.

作者信息

Dogan Abdullah, Tunc Bahattin, Ergene Oktay, Ozaydin Mehmet, Nazli Cem, Altinbas Ahmet, Gedikli Omer

机构信息

Department of Cardiology, Suleyman Demirel University, Medical School, Isparta, Turkey.

出版信息

Int J Cardiovasc Imaging. 2003 Dec;19(6):465-71. doi: 10.1023/b:caim.0000004339.30038.8d.

DOI:10.1023/b:caim.0000004339.30038.8d
PMID:14690185
Abstract

OBJECTIVE

Since the role of fibrinolytic activity is unclear in coronary artery ectasia, we investigated the entire fibrinolytic activity by a new test, global fibrinolytic capacity (GFC) in the ectasia patients.

METHODS AND RESULTS

Thirty-four ectasia patients (18 male, mean age: 58 +/- 8 years) presenting with acute coronary syndrome and 25 controls (14 male, mean age: 56 +/- 9 years) with normal coronary artery were evaluated. GFC, D-dimer and other hemostatic factors were assessed. Clinical characteristics were comparable in both groups. Serum GFC (4.6 +/- 2.1 vs. 3.1 +/- 2.1 microg/ml, p = 0.03) and D-dimer levels (0.69 +/- 0.42 vs. 0.41 +/- 0.38 ng/ml, p = 0.02, respectively) were significantly higher in ectasia patients than in controls. They were also higher in subgroup of patients with myocardial infarction (four patients) compared with other ectasia patients and controls (p = 0.04, 0.01, respectively). Other hemostatic factors were not different in both groups. GFC was correlated with D-dimer (r = 0.76, p = 0.01).

CONCLUSION

Our results suggest that fibrinolytic system activation may develop in ectasia patients with acute coronary syndrome. It can be induced by thrombus formation in ectatic segment of coronary artery.

摘要

目的

由于纤溶活性在冠状动脉扩张中的作用尚不清楚,我们通过一项新的检测方法——整体纤溶能力(GFC),对冠状动脉扩张患者的整体纤溶活性进行了研究。

方法与结果

对34例表现为急性冠状动脉综合征的冠状动脉扩张患者(18例男性,平均年龄:58±8岁)和25例冠状动脉正常的对照组患者(14例男性,平均年龄:56±9岁)进行了评估。评估了GFC、D - 二聚体及其他止血因子。两组的临床特征具有可比性。冠状动脉扩张患者的血清GFC(4.6±2.1 vs. 3.1±2.1微克/毫升,p = 0.03)和D - 二聚体水平(分别为0.69±0.42 vs. 0.41±0.38纳克/毫升,p = 0.02)显著高于对照组。与其他冠状动脉扩张患者及对照组相比,心肌梗死患者亚组(4例患者)的GFC和D - 二聚体水平也更高(分别为p = 0.04,0.01)。两组的其他止血因子无差异。GFC与D - 二聚体相关(r = 0.76,p = 0.01)。

结论

我们的结果表明,急性冠状动脉综合征的冠状动脉扩张患者可能发生纤溶系统激活。它可能由冠状动脉扩张段的血栓形成所诱导。

相似文献

1
Evaluation of overall fibrinolytic activity in patients with coronary artery ectasia: global fibrinolytic capacity.冠状动脉扩张患者整体纤溶活性的评估:整体纤溶能力。
Int J Cardiovasc Imaging. 2003 Dec;19(6):465-71. doi: 10.1023/b:caim.0000004339.30038.8d.
2
Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state.多囊卵巢综合征患者的整体纤维蛋白溶解能力下降,提示存在血栓前状态。
J Clin Endocrinol Metab. 2002 Aug;87(8):3871-5. doi: 10.1210/jcem.87.8.8716.
3
Disequilibrium of Blood Coagulation and Fibrinolytic System in Patients With Coronary Artery Ectasia.冠状动脉扩张患者凝血与纤溶系统失衡
Medicine (Baltimore). 2016 Feb;95(8):e2779. doi: 10.1097/MD.0000000000002779.
4
Global fibrinolytic capacity in children on dialysis.接受透析治疗儿童的全球纤溶能力。
Thromb Res. 2005;115(3):185-9. doi: 10.1016/j.thromres.2004.08.014.
5
Unchanged global fibrinolytic capacity during the course of hematopoietic stem cell transplantation.造血干细胞移植过程中全球纤溶能力无变化。
Blood Coagul Fibrinolysis. 2006 Jan;17(1):47-51. doi: 10.1097/01.mbc.0000200521.71046.d6.
6
Association of thrombotic and fibrinolytic factors with severity of culprit lesion in patients with acute coronary syndromes without ST elevation.非ST段抬高型急性冠脉综合征患者中血栓形成与纤溶因子与罪犯病变严重程度的关联
South Med J. 2010 Apr;103(4):289-94. doi: 10.1097/SMJ.0b013e3181ccb3d7.
7
Effect of ectasia size or the ectasia ratio on the thrombosis in myocardial infarction frame count in patients with isolated coronary artery ectasia.扩张大小或扩张比例对孤立性冠状动脉扩张患者心肌梗死帧数血栓形成的影响。
Heart Vessels. 2005 Sep;20(5):199-202. doi: 10.1007/s00380-005-0831-y.
8
Increased heparin-releasable platelet factor 4 and D dimer in patients one month after the onset of acute myocardial infarction: persistent activation of platelets and the coagulation/fibrinolytic system.急性心肌梗死发病一个月后患者体内肝素可释放血小板因子4和D-二聚体增加:血小板及凝血/纤溶系统持续激活。
Int J Cardiol. 1994 Dec;47(1 Suppl):S7-12. doi: 10.1016/0167-5273(94)90320-4.
9
Exercise-induced myocardial ischemia in patients with coronary artery ectasia without obstructive coronary artery disease.
Int J Cardiol. 2001 Apr;78(2):143-9. doi: 10.1016/s0167-5273(01)00365-5.
10
[Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention].[冠心病急性期患者凝血与纤溶功能变化及药物干预效果]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 Apr;24(4):225-8.

引用本文的文献

1
Dual Antiplatelet Therapy Versus Antiplatelet Monotherapy Plus Oral Anticoagulation in Patients with Acute Coronary Syndrome and Coronary Artery Ectasia: Design and Rationale of OVER-TIME Randomized Clinical Trial.急性冠状动脉综合征合并冠状动脉扩张患者的双联抗血小板治疗与抗血小板单药治疗加口服抗凝治疗:OVER-TIME随机临床试验的设计与原理
High Blood Press Cardiovasc Prev. 2022 Sep;29(5):463-468. doi: 10.1007/s40292-022-00535-4. Epub 2022 Jul 29.
2
Relationship Between Plasma Levels of Soluble CD40 Ligand and the Presence and Severity of Isolated Coronary Artery Ectasia.可溶性CD40配体血浆水平与孤立性冠状动脉扩张的存在及严重程度之间的关系。
Clin Appl Thromb Hemost. 2018 Mar;24(2):379-386. doi: 10.1177/1076029616680476. Epub 2016 Nov 23.
3

本文引用的文献

1
Effect of trimetazidine on exercise performance in patients with coronary artery ectasia.曲美他嗪对冠状动脉扩张患者运动能力的影响。
Jpn Heart J. 2003 Jul;44(4):463-70. doi: 10.1536/jhj.44.463.
2
Coagulation activity and clinical outcome in unstable coronary artery disease.
Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):1059-64. doi: 10.1161/01.atv.21.6.1059.
3
Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis.纤维蛋白D - 二聚体与冠心病:前瞻性研究及荟萃分析
Disequilibrium of Blood Coagulation and Fibrinolytic System in Patients With Coronary Artery Ectasia.冠状动脉扩张患者凝血与纤溶系统失衡
Medicine (Baltimore). 2016 Feb;95(8):e2779. doi: 10.1097/MD.0000000000002779.
Circulation. 2001 May 15;103(19):2323-7. doi: 10.1161/01.cir.103.19.2323.
4
Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.纤溶因子与冠心病发病的前瞻性研究:社区动脉粥样硬化风险(ARIC)研究
Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):611-7. doi: 10.1161/01.atv.21.4.611.
5
Effect of temperature and incubation time on D-dimer serum levels in healthy subjects.温度和孵育时间对健康受试者血清D - 二聚体水平的影响。
Thromb Res. 2000 Mar 15;97(6):513-7. doi: 10.1016/s0049-3848(99)00204-2.
6
Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease.在年轻冠心病患者中,与体力应激试验相比,静脉闭塞后的纤溶反应。
Thromb Haemost. 1999 Sep;82 Suppl 1:80-4.
7
Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events.纤维蛋白原和纤维蛋白D-二聚体在预测动脉血栓形成事件中的应用。
Thromb Haemost. 1999 Aug;82(2):667-72.
8
Thrombogenic factors and recurrent coronary events.
Circulation. 1999 May 18;99(19):2517-22. doi: 10.1161/01.cir.99.19.2517.
9
Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study.纤溶激活标志物可预测老年人的心肌梗死。心血管健康研究。
Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):493-8. doi: 10.1161/01.atv.19.3.493.
10
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.急性心肌梗死患者接受溶栓治疗和肝素治疗时的凝血酶生成、抑制及临床结局:GUSTO-I试验结果。GUSTO-I止血亚研究组。链激酶和组织型纤溶酶原激活剂在闭塞冠状动脉中的全球应用。
J Am Coll Cardiol. 1998 Mar 1;31(3):497-505. doi: 10.1016/s0735-1097(97)00539-1.